Breaking News Instant updates and real-time market news.

BLRX

BioLineRx

07:07
11/21/16
11/21
07:07
11/21/16
07:07

BioLineRx signs agreement with Yissum Research Development Company

BioLineRx announced that it has signed an exclusive, worldwide agreement with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., for the in-licensing of a novel anti-inflammatory treatment for Dry Eye Syndrome. This project, to be named BL-1230, is the third project in-licensed under the framework of the Company's strategic collaboration with Novartis Pharma AG for the screening and development of novel drug candidates.

  • 22

    Nov

  • 03

    Dec

BLRX BioLineRx

03/22/16
ROTH
03/22/16
NO CHANGE
ROTH
BioLineRx BL-8040 could have 'dramatic impact,' says Roth Capital
Roth Capital expects Phase II data for BioLineRx's AML treatment, BL-8040, to be reported "imminently." The firm notes that interim data on the study reported late last year appeared to be positive. It thinks the drug could make "a dramatic impact" on AML, and Roth says that BioLineRx's fundamentals have improved. It reiterates a $7 price target and Buy rating on the shares.
08/12/16
MAXM
08/12/16
DOWNGRADE
MAXM
Hold
BioLineRx downgraded to Hold from Buy at Maxim
09/07/16
09/07/16
NO CHANGE

BioLineRx partnering with Roche company in cancer therapy research
BioLineRx (BLRX) has entered into a collaboration with Genentech, a member of the Roche (RHHBY) Group, to support several Phase 1b studies investigating BioLineRx's BL-8040 in combination with Atezolizumab, Genentech's anti-PDL1 cancer immunotherapy, in multiple cancer indications. The Phase 1b studies will evaluate the clinical response, safety and tolerability of the combination of these therapies, as well as multiple pharmacodynamic parameters, in hematologic malignancies and solid tumors. Under the agreement, Genentech will sponsor and conduct several Phase 1b trials in multiple solid cancer indications. In addition, BioLineRx will sponsor and conduct a Phase 1b study in acute myeloid leukemia patients. The studies are designed to evaluate the safety and efficacy of the combination of BL-8040 and Atezolizumab. Upon completion of the studies, both parties will have the option to expand the collaboration to include a pivotal registration study. Additional details of the collaboration were not disclosed.

TODAY'S FREE FLY STORIES

MLHR

Herman Miller

$40.95

0.4 (0.99%)

10:25
01/23/18
01/23
10:25
01/23/18
10:25
Conference/Events
Herman Miller management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 30

    Jan

  • 31

    Jan

10:25
01/23/18
01/23
10:25
01/23/18
10:25
Conference/Events
RBC Capital software analysts hold an analyst/industry conference call »

Software Analysts…

RARE

Ultragenyx

$53.39

4.23 (8.60%)

10:25
01/23/18
01/23
10:25
01/23/18
10:25
Conference/Events
Ultragenyx participates in a conference call with JPMorgan »

Investor conference call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 17

    Apr

  • 24

    Jan

LLEX

Lilis Energy

$4.86

-0.14 (-2.80%)

10:24
01/23/18
01/23
10:24
01/23/18
10:24
Conference/Events
Lilis Energy management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 31

    Jan

EBAY

eBay

$39.58

1.15 (2.99%)

, GOOG

Alphabet

$1,155.81

18.3 (1.61%)

10:21
01/23/18
01/23
10:21
01/23/18
10:21
Periodicals
eBay CEO says shoppers are shifting to voice technology, CNBC reports »

eBay (EBAY) CEO Devin…

EBAY

eBay

$39.58

1.15 (2.99%)

GOOG

Alphabet

$1,155.81

18.3 (1.61%)

GOOGL

Alphabet Class A

$1,164.16

20.66 (1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 01

    Feb

  • 01

    Feb

  • 07

    Feb

  • 28

    Feb

  • 18

    Mar

CMD

Cantel Medical

$112.00

0.7 (0.63%)

10:21
01/23/18
01/23
10:21
01/23/18
10:21
Conference/Events
Cantel Medical management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 31

    Jan

KMB

Kimberly-Clark

$116.87

-0.04 (-0.03%)

10:20
01/23/18
01/23
10:20
01/23/18
10:20
Hot Stocks
Kimberly-Clark sees 2H18 EPS higher than 1H18 »

On its Q4 earnings call,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

10:20
01/23/18
01/23
10:20
01/23/18
10:20
General news
Nasdaq leads major averages as Netflix jumps after earnings »

Stock futures were little…

JAX

J. Alexander's

$10.23

-0.275 (-2.62%)

10:20
01/23/18
01/23
10:20
01/23/18
10:20
Conference/Events
J. Alexander's to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

FTI

TechnipFMC

$34.30

-0.29 (-0.84%)

10:20
01/23/18
01/23
10:20
01/23/18
10:20
Options
Bullish flow in TechnipFMC »

Bullish flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

10:20
01/23/18
01/23
10:20
01/23/18
10:20
General news
U.S. January Richmond Fed manufacturing index slumped 6 points to 14 »

U.S. January Richmond Fed…

$NSD

NASDAQ Market Internals

10:17
01/23/18
01/23
10:17
01/23/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

10:16
01/23/18
01/23
10:16
01/23/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
01/23/18
01/23
10:15
01/23/18
10:15
General news
Treasury Action: yields consolidated above lows »

Treasury Action: yields…

CAMP

CalAmp

$23.13

0.02 (0.09%)

10:15
01/23/18
01/23
10:15
01/23/18
10:15
Conference/Events
CalAmp has a conference call hosted by JPMorgan »

JPMorgan Analyst Coster…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

TSLA

Tesla

$351.56

1.54 (0.44%)

10:12
01/23/18
01/23
10:12
01/23/18
10:12
Recommendations
Tesla analyst commentary  »

Tesla performance plan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEM

MSCI Emerging Markets Index

10:10
01/23/18
01/23
10:10
01/23/18
10:10
Options
Sizable spread in iShares Emerging Markets Fund as shares ease off 52-week highs »

Sizable spread in iShares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:10
01/23/18
01/23
10:10
01/23/18
10:10
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

FCX

Freeport McMoRan

$19.15

-0.84 (-4.20%)

10:09
01/23/18
01/23
10:09
01/23/18
10:09
Technical Analysis
Technical Take: Freeport McMoRan hits session lows, levels to watch »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

TM

Toyota

$139.52

0.12 (0.09%)

10:09
01/23/18
01/23
10:09
01/23/18
10:09
Hot Stocks
Toyota surpasses 3,000 Mirai hydrogen fuel cell vehicle sales in California »

The Toyota Mirai, one of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

VRX

Valeant

$22.65

0.62 (2.81%)

10:05
01/23/18
01/23
10:05
01/23/18
10:05
Options
Valeant call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 18

    Jun

  • 27

    Aug

ARD

Ardagh Group

$19.95

-0.04 (-0.20%)

10:02
01/23/18
01/23
10:02
01/23/18
10:02
Hot Stocks
Ardagh Group announces nationwide rollout of Ardagh Direct program »

Ardagh Group, Glass -…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$22.71

-0.614 (-2.63%)

10:02
01/23/18
01/23
10:02
01/23/18
10:02
Recommendations
Twitter analyst commentary  »

Noto exit may suggest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

10:01
01/23/18
01/23
10:01
01/23/18
10:01
General news
Richmond Fed Manufacturing Index Level data reported »

January Richmond Fed…

HON

Honeywell

$159.57

1.03 (0.65%)

10:01
01/23/18
01/23
10:01
01/23/18
10:01
Hot Stocks
Honeywell to provide third cryogenic gas processing plat to Brazos Midstream »

Honeywell announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jan

  • 25

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.